Atypical chronic myeloid leukemia (CML) with ETV6-ABL1 mutation managed successfully with a third-generation TKI and hematopoietic stem cell transplant
Dehghani SS, Wang Y, Ramesh KH, Cooper D, Verceles JA, Boakye K, Konopleva M, Friedman EW, Shastri A
У данной статьи нет абстракта.
Leukemia & lymphoma, 2024-10-20